152 related articles for article (PubMed ID: 29481948)
1. Enhanced dissolution of solid dispersions containing bicalutamide subjected to mechanical stress.
Szafraniec J; Antosik A; Knapik-Kowalczuk J; Chmiel K; Kurek M; Gawlak K; Paluch M; Jachowicz R
Int J Pharm; 2018 May; 542(1-2):18-26. PubMed ID: 29481948
[TBL] [Abstract][Full Text] [Related]
2. Planetary ball milling and supercritical fluid technology as a way to enhance dissolution of bicalutamide.
Szafraniec J; Antosik A; Knapik-Kowalczuk J; Kurek M; Syrek K; Chmiel K; Paluch M; Jachowicz R
Int J Pharm; 2017 Nov; 533(2):470-479. PubMed ID: 28363855
[TBL] [Abstract][Full Text] [Related]
3. Development and characterization of bicalutamide-poloxamer F68 solid dispersion systems.
Sancheti PP; Vyas VM; Shah M; Karekar P; Pore YV
Pharmazie; 2008 Aug; 63(8):571-5. PubMed ID: 18771004
[TBL] [Abstract][Full Text] [Related]
4. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
Patil AL; Pore YV; Kuchekar BS; Late SG
Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387
[TBL] [Abstract][Full Text] [Related]
5. Tabletting solid dispersions of bicalutamide prepared using ball-milling or supercritical carbon dioxide: the interrelationship between phase transition and
Antosik-Rogóż A; Szafraniec-Szczęsny J; Gawlak K; Knapik-Kowalczuk J; Paluch M; Jachowicz R
Pharm Dev Technol; 2020 Nov; 25(9):1109-1117. PubMed ID: 32686538
[TBL] [Abstract][Full Text] [Related]
6. Co-crystallization for enhanced dissolution rate of bicalutamide: preparation and evaluation of rapidly disintegrating tablets.
Essa EA; Elbasuony AR; Abdelaziz AE; El Maghraby GM
Drug Dev Ind Pharm; 2019 Aug; 45(8):1215-1223. PubMed ID: 30661420
[No Abstract] [Full Text] [Related]
7. Formation of bicalutamide nanodispersion for dissolution rate enhancement.
Li C; Li C; Le Y; Chen JF
Int J Pharm; 2011 Feb; 404(1-2):257-63. PubMed ID: 21093558
[TBL] [Abstract][Full Text] [Related]
8. Nanosized bicalutamide and its molecular structure in solvents.
Le Y; Ji H; Chen JF; Shen Z; Yun J; Pu M
Int J Pharm; 2009 Mar; 370(1-2):175-80. PubMed ID: 19101616
[TBL] [Abstract][Full Text] [Related]
9. Improving the physicochemical properties of bicalutamide by complex formation with bovine serum albumin.
Yang C; Di P; Fu J; Xiong H; Jing Q; Ren G; Tang Y; Zheng W; Liu G; Ren F
Eur J Pharm Sci; 2017 Aug; 106():381-392. PubMed ID: 28571783
[TBL] [Abstract][Full Text] [Related]
10. Understanding the performance of melt-extruded poly(ethylene oxide)-bicalutamide solid dispersions: characterisation of microstructural properties using thermal, spectroscopic and drug release methods.
Abu-Diak OA; Jones DS; Andrews GP
J Pharm Sci; 2012 Jan; 101(1):200-13. PubMed ID: 21905037
[TBL] [Abstract][Full Text] [Related]
11. Spherical agglomeration to improve dissolution and micromeritic properties of an anticancer drug, Bicalutamide.
Dalvadi H; Parmar K; Yadav S
Drug Dev Ind Pharm; 2019 Jun; 45(6):968-980. PubMed ID: 30784326
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of bicalutamide solid dispersions and improvement of the dissolution.
Ren F; Jing Q; Tang Y; Shen Y; Chen J; Gao F; Cui J
Drug Dev Ind Pharm; 2006 Sep; 32(8):967-72. PubMed ID: 16954109
[TBL] [Abstract][Full Text] [Related]
13. Improving the wetting and dissolution of ibuprofen using solventless co-milling.
Varghese S; Ghoroi C
Int J Pharm; 2017 Nov; 533(1):145-155. PubMed ID: 28951348
[TBL] [Abstract][Full Text] [Related]
14. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer.
Ray S; Ghosh Ray S; Mandal S
Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):944-954. PubMed ID: 27327352
[TBL] [Abstract][Full Text] [Related]
15. Monitoring the Dissolution Mechanisms of Amorphous Bicalutamide Solid Dispersions via Real-Time Raman Mapping.
Tres F; Patient JD; Williams PM; Treacher K; Booth J; Hughes LP; Wren SA; Aylott JW; Burley JC
Mol Pharm; 2015 May; 12(5):1512-22. PubMed ID: 25872658
[TBL] [Abstract][Full Text] [Related]
16. Preparation and physicochemical characterizations of tanshinone IIA solid dispersion.
Zhao X; Liu X; Gan L; Zhou C; Mo J
Arch Pharm Res; 2011 Jun; 34(6):949-59. PubMed ID: 21725816
[TBL] [Abstract][Full Text] [Related]
17. The Self-Assembly Phenomenon of Poloxamers and Its Effect on the Dissolution of a Poorly Soluble Drug from Solid Dispersions Obtained by Solvent Methods.
Szafraniec J; Antosik A; Knapik-Kowalczuk J; Chmiel K; Kurek M; Gawlak K; Odrobińska J; Paluch M; Jachowicz R
Pharmaceutics; 2019 Mar; 11(3):. PubMed ID: 30893859
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.
Andrews GP; AbuDiak OA; Jones DS
J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757
[TBL] [Abstract][Full Text] [Related]
19. How Does the CO
Antosik-Rogóż A; Szafraniec-Szczęsny J; Chmiel K; Knapik-Kowalczuk J; Kurek M; Gawlak K; Danesi VP; Paluch M; Jachowicz R
Materials (Basel); 2020 Jun; 13(12):. PubMed ID: 32630453
[TBL] [Abstract][Full Text] [Related]
20. Free flowing solid dispersions of the anti-HIV drug UC 781 with Poloxamer 407 and a maximum amount of TPGS 1000: investigating the relationship between physicochemical characteristics and dissolution behaviour.
Goddeeris C; Van den Mooter G
Eur J Pharm Sci; 2008 Sep; 35(1-2):104-13. PubMed ID: 18644442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
